Click for best price
Oral Antidiabetic Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 1897.4 million
|
Forecast Market size by 2029 |
US$ 2328.3 million
|
| Growth Rate |
CAGR of 3.0% |
Number of Pages |
68 Pages |
The global Oral Antidiabetic Drugs market was valued at US$ 1897.4 million in 2022 and is projected to reach US$ 2328.3 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Oral Antidiabetic Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Oral Antidiabetic Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Oral Antidiabetic Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Diabetes mellitus is a group of a metabolic disorder caused when the body is unable to produce required quantity of Insulin. Insulin is a hormone secreted by beta cells of the islet of Langerhans of the pancreas. Various symptoms associated with diabetes disorder include recurrent urination, increased thirst, and hunger. Diabetes can cause much chronic complication if left untreated. Some of them include acute complications like diabetic ketoacidosis, chronic kidney failure, foot ulcers, and damage to the eyes.
This report aims to provide a comprehensive presentation of the global market for Oral Antidiabetic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antidiabetic Drugs. This report contains market size and forecasts of Oral Antidiabetic Drugs in global, including the following market information:
- Global Oral Antidiabetic Drugs Market Revenue, 2018-2023, 20242035, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sulfonylureas Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oral Antidiabetic Drugs include Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma, Novartis, Novo Nordisk, Merck and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Antidiabetic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Antidiabetic Drugs Market, by Type, 2018-2023, 20242035 ($ millions)
Global Oral Antidiabetic Drugs Market Segment Percentages, by Type, 2022 (%)
- Sulfonylureas
- Meglitinides
- Alpha-glucosidase inhibitors
Global Oral Antidiabetic Drugs Market, by Application, 2018-2023, 20242035 ($ millions)
Global Oral Antidiabetic Drugs Market Segment Percentages, by Application, 2022 (%)
Global Oral Antidiabetic Drugs Market, By Region and Country, 2018-2023, 20242035 ($ Millions)
Global Oral Antidiabetic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Oral Antidiabetic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Oral Antidiabetic Drugs revenues share in global market, 2022 (%)
key players include:
- Eli Lilly
- Abbott
- Biocon
- Sanofi
- Sunpharma
- Novartis
- Novo Nordisk
- Merck
- Pfizer
- Huadong Medicine Co.,Ltd.
- Lepu Medical
- Hengrui Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Antidiabetic Drugs, market overview.
Chapter 2: Global Oral Antidiabetic Drugs market size in revenue.
Chapter 3: Detailed analysis of Oral Antidiabetic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Antidiabetic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Oral Antidiabetic Drugs Market, Global Outlook and Forecast 2023-2035 |
| Market size in 2022 |
US$ 1897.4 million
|
| Forecast Market size by 2029 |
US$ 2328.3 million
|
| Growth Rate |
CAGR of 3.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oral Antidiabetic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Antidiabetic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Antidiabetic Drugs Overall Market Size
2.1 Global Oral Antidiabetic Drugs Market Size: 2022 VS 2035
2.2 Global Oral Antidiabetic Drugs Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oral Antidiabetic Drugs Players in Global Market
3.2 Top Global Oral Antidiabetic Drugs Companies Ranked by Revenue
3.3 Global Oral Antidiabetic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Oral Antidiabetic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oral Antidiabetic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oral Antidiabetic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Oral Antidiabetic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Oral Antidiabetic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oral Antidiabetic Drugs Market Size Markets, 2022 & 2035
4.1.2 Sulfonylureas
4.1.3 Meglitinides
4.1.4 Alpha-glucosidase inhibitors
4.2 By Type - Global Oral Antidiabetic Drugs Revenue & Forecasts
4.2.1 By Type - Global Oral Antidiabetic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Oral Antidiabetic Drugs Revenue, 2024-2035
4.2.3 By Type - Global Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oral Antidiabetic Drugs Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Oral Antidiabetic Drugs Revenue & Forecasts
5.2.1 By Application - Global Oral Antidiabetic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Oral Antidiabetic Drugs Revenue, 2024-2035
5.2.3 By Application - Global Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Oral Antidiabetic Drugs Market Size, 2022 & 2035
6.2 By Region - Global Oral Antidiabetic Drugs Revenue & Forecasts
6.2.1 By Region - Global Oral Antidiabetic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Oral Antidiabetic Drugs Revenue, 2024-2035
6.2.3 By Region - Global Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Oral Antidiabetic Drugs Revenue, 2018-2035
6.3.2 US Oral Antidiabetic Drugs Market Size, 2018-2035
6.3.3 Canada Oral Antidiabetic Drugs Market Size, 2018-2035
6.3.4 Mexico Oral Antidiabetic Drugs Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Oral Antidiabetic Drugs Revenue, 2018-2035
6.4.2 Germany Oral Antidiabetic Drugs Market Size, 2018-2035
6.4.3 France Oral Antidiabetic Drugs Market Size, 2018-2035
6.4.4 U.K. Oral Antidiabetic Drugs Market Size, 2018-2035
6.4.5 Italy Oral Antidiabetic Drugs Market Size, 2018-2035
6.4.6 Russia Oral Antidiabetic Drugs Market Size, 2018-2035
6.4.7 Nordic Countries Oral Antidiabetic Drugs Market Size, 2018-2035
6.4.8 Benelux Oral Antidiabetic Drugs Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Oral Antidiabetic Drugs Revenue, 2018-2035
6.5.2 China Oral Antidiabetic Drugs Market Size, 2018-2035
6.5.3 Japan Oral Antidiabetic Drugs Market Size, 2018-2035
6.5.4 South Korea Oral Antidiabetic Drugs Market Size, 2018-2035
6.5.5 Southeast Asia Oral Antidiabetic Drugs Market Size, 2018-2035
6.5.6 India Oral Antidiabetic Drugs Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Oral Antidiabetic Drugs Revenue, 2018-2035
6.6.2 Brazil Oral Antidiabetic Drugs Market Size, 2018-2035
6.6.3 Argentina Oral Antidiabetic Drugs Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oral Antidiabetic Drugs Revenue, 2018-2035
6.7.2 Turkey Oral Antidiabetic Drugs Market Size, 2018-2035
6.7.3 Israel Oral Antidiabetic Drugs Market Size, 2018-2035
6.7.4 Saudi Arabia Oral Antidiabetic Drugs Market Size, 2018-2035
6.7.5 UAE Oral Antidiabetic Drugs Market Size, 2018-2035
7 Oral Antidiabetic Drugs Companies Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Oral Antidiabetic Drugs Major Product Offerings
7.1.4 Eli Lilly Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Oral Antidiabetic Drugs Major Product Offerings
7.2.4 Abbott Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Biocon
7.3.1 Biocon Company Summary
7.3.2 Biocon Business Overview
7.3.3 Biocon Oral Antidiabetic Drugs Major Product Offerings
7.3.4 Biocon Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.3.5 Biocon Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Oral Antidiabetic Drugs Major Product Offerings
7.4.4 Sanofi Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Sunpharma
7.5.1 Sunpharma Company Summary
7.5.2 Sunpharma Business Overview
7.5.3 Sunpharma Oral Antidiabetic Drugs Major Product Offerings
7.5.4 Sunpharma Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.5.5 Sunpharma Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Oral Antidiabetic Drugs Major Product Offerings
7.6.4 Novartis Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Oral Antidiabetic Drugs Major Product Offerings
7.7.4 Novo Nordisk Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Oral Antidiabetic Drugs Major Product Offerings
7.8.4 Merck Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Oral Antidiabetic Drugs Major Product Offerings
7.9.4 Pfizer Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Huadong Medicine Co.,Ltd.
7.10.1 Huadong Medicine Co.,Ltd. Company Summary
7.10.2 Huadong Medicine Co.,Ltd. Business Overview
7.10.3 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Major Product Offerings
7.10.4 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.10.5 Huadong Medicine Co.,Ltd. Key News & Latest Developments
7.11 Lepu Medical
7.11.1 Lepu Medical Company Summary
7.11.2 Lepu Medical Business Overview
7.11.3 Lepu Medical Oral Antidiabetic Drugs Major Product Offerings
7.11.4 Lepu Medical Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.11.5 Lepu Medical Key News & Latest Developments
7.12 Hengrui Medicine
7.12.1 Hengrui Medicine Company Summary
7.12.2 Hengrui Medicine Business Overview
7.12.3 Hengrui Medicine Oral Antidiabetic Drugs Major Product Offerings
7.12.4 Hengrui Medicine Oral Antidiabetic Drugs Revenue in Global Market (2018-2023)
7.12.5 Hengrui Medicine Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oral Antidiabetic Drugs Market Opportunities & Trends in Global Market
Table 2. Oral Antidiabetic Drugs Market Drivers in Global Market
Table 3. Oral Antidiabetic Drugs Market Restraints in Global Market
Table 4. Key Players of Oral Antidiabetic Drugs in Global Market
Table 5. Top Oral Antidiabetic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oral Antidiabetic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oral Antidiabetic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oral Antidiabetic Drugs Product Type
Table 9. List of Global Tier 1 Oral Antidiabetic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Antidiabetic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oral Antidiabetic Drugs Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Oral Antidiabetic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oral Antidiabetic Drugs Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Oral Antidiabetic Drugs Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Oral Antidiabetic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oral Antidiabetic Drugs Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Oral Antidiabetic Drugs Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Oral Antidiabetic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oral Antidiabetic Drugs Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oral Antidiabetic Drugs Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oral Antidiabetic Drugs Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oral Antidiabetic Drugs Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oral Antidiabetic Drugs Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oral Antidiabetic Drugs Revenue, (US$, Mn), 2024-2035
Table 30. Eli Lilly Company Summary
Table 31. Eli Lilly Oral Antidiabetic Drugs Product Offerings
Table 32. Eli Lilly Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Eli Lilly Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Oral Antidiabetic Drugs Product Offerings
Table 36. Abbott Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Key News & Latest Developments
Table 38. Biocon Company Summary
Table 39. Biocon Oral Antidiabetic Drugs Product Offerings
Table 40. Biocon Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Biocon Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Oral Antidiabetic Drugs Product Offerings
Table 44. Sanofi Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. Sunpharma Company Summary
Table 47. Sunpharma Oral Antidiabetic Drugs Product Offerings
Table 48. Sunpharma Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Sunpharma Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Oral Antidiabetic Drugs Product Offerings
Table 52. Novartis Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Novo Nordisk Company Summary
Table 55. Novo Nordisk Oral Antidiabetic Drugs Product Offerings
Table 56. Novo Nordisk Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Novo Nordisk Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Oral Antidiabetic Drugs Product Offerings
Table 60. Merck Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Oral Antidiabetic Drugs Product Offerings
Table 64. Pfizer Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Huadong Medicine Co.,Ltd. Company Summary
Table 67. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Product Offerings
Table 68. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Huadong Medicine Co.,Ltd. Key News & Latest Developments
Table 70. Lepu Medical Company Summary
Table 71. Lepu Medical Oral Antidiabetic Drugs Product Offerings
Table 72. Lepu Medical Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Lepu Medical Key News & Latest Developments
Table 74. Hengrui Medicine Company Summary
Table 75. Hengrui Medicine Oral Antidiabetic Drugs Product Offerings
Table 76. Hengrui Medicine Oral Antidiabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Hengrui Medicine Key News & Latest Developments
List of Figures
Figure 1. Oral Antidiabetic Drugs Segment by Type in 2022
Figure 2. Oral Antidiabetic Drugs Segment by Application in 2022
Figure 3. Global Oral Antidiabetic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oral Antidiabetic Drugs Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Oral Antidiabetic Drugs Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oral Antidiabetic Drugs Revenue in 2022
Figure 8. By Type - Global Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
Figure 9. By Application - Global Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
Figure 10. By Type - Global Oral Antidiabetic Drugs Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
Figure 12. By Application - Global Oral Antidiabetic Drugs Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
Figure 14. By Region - Global Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
Figure 15. By Country - North America Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
Figure 16. US Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
Figure 20. Germany Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 21. France Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
Figure 28. China Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 32. India Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
Figure 34. Brazil Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Oral Antidiabetic Drugs Revenue Market Share, 2018-2035
Figure 37. Turkey Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Oral Antidiabetic Drugs Revenue, (US$, Mn), 2018-2035
Figure 41. Eli Lilly Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Biocon Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sunpharma Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novo Nordisk Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Lepu Medical Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Hengrui Medicine Oral Antidiabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
